心血管设备市场规模、份额、成长分析、按产品、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球心血管器材市场规模估值为449亿美元，从2023年的491亿美元成长到2031年的949亿美元，预测期内（2024-2031年）复合年增长率为8.5，预计将成长8.5%。

在慢性心血管疾病盛行率上升的推动下，全球心血管设备市场正经历强劲成长。哈佛大学陈曾熙公共卫生学院的一项研究指出，印度马哈拉斯特拉邦拉邦的心臟麻痹增加了 43%，这归因于冠状动脉支架成本的下降。心臟关键药物（尤其是冠状动脉绕道手术疗法）价格的下降进一步支持了市场扩张，特别是在印度等新兴经济体。主要成长动力包括快速的技术进步、全球心血管疾病负担的增加以及向微创治疗方法的转变。此外，心臟设备製造的创新扩大了适应症并改善了患者管理，使心律调节器等设备在全球心臟病的有效诊断和治疗中发挥重要作用已变得显而易见。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析及影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 专利分析
• 价值链分析
• PESTEL分析
• 总体经济指标
• 市场吸引力指数

心血管设备市场规模：依产品及复合年增长率（2024-2031）

• 市场概况
• 诊断和监测设备
  • 心电图
  • 植入式心臟监测仪
  • 心电图监测
  • 移动心电遥测
  • MRI
  • 心血管超音波检查
  • 2D
  • 3D/4D
  • 多普勒
  • 心臟诊断导管
  • 正子断层扫描仪
• 手术设备
  • 心臟再同步治疗（CRT）
  • CRT心臟去颤器
  • CRT心律调节器
  • 植入式心臟整流去颤器(ICD)
  • 单腔ICD
  • 双腔室ICD
  • 心律调节器
  • 传统心律调节器
  • 无导线心律调节器
  • 冠状动脉支架
  • 导管
  • 导管导引线
  • 插管
  • 阀门
  • 阻塞设备

心血管设备市场规模：依应用与复合年增长率（2024-2031）

• 市场概况
• 冠状动脉疾病（CAD）
• 心律不整
• 心臟衰竭
• 其他的

心血管设备市场规模：依最终用户和复合年增长率（2024-2031）

• 市场概况
• 医院
• 专科诊所
• 其他的

心血管设备市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic, Inc.
• Johnson & Johnson
• Terumo Corporation
• Edwards Lifesciences Corporation
• Biotronik SE & Co. KG
• LivaNova PLC
• Getinge AB
• Baxter International Inc.（Hill-Rom Holdings, Inc.）
• Koninklijke Philips NV
• Siemens Healthineers AG
• GE Healthcare
• Toshiba Corporation
• Fujifilm Holdings Corporation
• Hitachi, Ltd.
• Nihon Kohden Corporation
• Collateral Medical Pvt. Ltd.
• Schiller AG
• B. Braun Melsungen AG

结论和建议

Global Cardiovascular Devices Market size was valued at USD 44.9 billion in 2022 and is poised to grow from USD 49.1 billion in 2023 to USD 94.9 billion by 2031, growing at a CAGR of 8.5% during the forecast period (2024-2031).

The global cardiovascular device market is experiencing robust growth, driven by the rising incidence of chronic cardiovascular diseases. A study from Harvard's T.H. Chan School of Public Health highlights a 43% surge in cardiac arrests in Maharashtra, India, attributed to the reduced costs of coronary stents. The decline in essential cardiac drug prices, notably coronary artery bypass therapy, is further propelling market expansion, particularly in emerging economies like India. Key growth drivers include rapid technological advancements, a rising global burden of cardiovascular conditions, and a shift towards less invasive treatment options. Additionally, innovation in cardiac device manufacturing has broadened indications and improved patient management, underscoring the vital role of devices like pacemakers in effectively diagnosing and treating heart diseases globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiovascular Devices Market Segmental Analysis

Global Cardiovascular Devices Market is segmented by product, application, end user and region. Based on product, the market is segmented into Diagnostic & Monitoring Devices (ECG, Implantable Cardiac Monitors, Holter Monitors, Mobile Cardiac Telemetry, MRI, Cardiovascular Ultrasound (2D, 3D/4D, Doppler), Cardiac Diagnostic Catheters, PET Scanner), Surgical Devices (Cardiac Resynchronization Therapy (CRT) (CRT-Defibrillator, CRT-Pacemaker), Implantable Cardioverter Defibrillators (ICDs) (Single Chamber ICDs, Dual Chamber ICDs), Pacemakers (Conventional Pacemakers, Leadless Pacemakers), Coronary Stents, Catheters, Guidewires, Cannula, Valves, Occlusion Devices). Based on application, the market is segmented into Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure and Others. Based on end user, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiovascular Devices Market

The Global Cardiovascular Devices market is significantly influenced by the escalating incidence of cardiovascular diseases (CVDs), which remain the foremost cause of mortality worldwide. The rising prevalence of sedentary lifestyles, unhealthy diets, and an aging demographic contributes to an increased risk of conditions like congestive heart failure, hypertension, and heart failure. As a result, there is a growing necessity for vital medical devices, including pacemakers, defibrillators, and stents, particularly in both developed and developing regions. Health systems are now focusing on preventive care and early disease detection, while hospitals and clinics adopt advanced technologies to enhance patient outcomes. Furthermore, government initiatives and nonprofit organizations are actively promoting awareness among high-risk populations, further driving the market's growth.

Restraints in the Global Cardiovascular Devices Market

One significant constraint faced by the global cardiovascular devices market is the high cost associated with advanced equipment. This challenge is particularly pronounced in developing regions where the affordability of advanced devices, such as implantable cardioverter defibrillators (ICDs) and sophisticated imaging technologies, proves to be a substantial hurdle. The hefty price tags attached to these devices can deter healthcare providers and patients alike, limiting their availability and accessibility. Furthermore, inadequate insurance coverage and reimbursement options in certain areas exacerbate this issue, leaving patients without access to potentially life-saving technologies, ultimately hindering the growth and adoption of cardiovascular interventions.

Market Trends of the Global Cardiovascular Devices Market

The Global Cardiovascular Devices market is experiencing a significant shift towards expanding home health solutions, driven by the increasing demand for self-management tools and remote patient monitoring technologies. Wearable ECG devices, blood pressure monitors, and other innovative remote monitoring solutions enable patients to capture real-time health data, empowering them to manage chronic conditions like heart failure more effectively from the comfort of their homes. This trend not only improves patient convenience and engagement but also reduces healthcare costs and enhances the focus on preventive care. As patients seek greater autonomy in managing their health, the market is poised for sustained growth and innovation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index

Global Cardiovascular Devices Market Size by Product & CAGR (2024-2031)

• Market Overview
• Diagnostic & Monitoring Devices
  • ECG
  • Implantable Cardiac Monitors
  • Holter Monitors
  • Mobile Cardiac Telemetry
  • MRI
  • Cardiovascular Ultrasound
  • 2D
  • 3D/4D
  • Doppler
  • Cardiac Diagnostic Catheters
  • PET Scanner
• Surgical Devices
  • Cardiac Resynchronization Therapy (CRT)
  • CRT-Defibrillator
  • CRT-Pacemaker
  • Implantable Cardioverter Defibrillators (ICDs)
  • Single Chamber ICDs
  • Dual Chamber ICDs
  • Pacemakers
  • Conventional Pacemakers
  • Leadless Pacemakers
  • Coronary Stents
  • Catheters
  • Guidewires
  • Cannula
  • Valves
  • Occlusion Devices

Global Cardiovascular Devices Market Size by Application & CAGR (2024-2031)

• Market Overview
• Coronary Artery Disease (CAD)
• Cardiac Arrhythmia
• Heart Failure
• Others

Global Cardiovascular Devices Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Cardiovascular Devices Market Size & CAGR (2024-2031)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (Hill-Rom Holdings, Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toshiba Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collateral Medical Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation